Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
The mTOR/S6K1 signaling pathway is often activated in cervical cancer, and thus considered a molecular target for cervical cancer therapies. Inhibiting mTOR is cytotoxic to cervical cancer cells and creates a synergistic anti-tumor effect with conventional chemotherapy agents. | Identification of a novel S6K1 inhibitor rosmarinic acid methyl ester for treating cisplatin-resistant cervical cancer